226950.KQ
OliX Pharmaceuticals,Inc
KOE · Healthcare · Biotechnology · KR
KRW 114,200.00
+2.79%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.74x
- Price / sales
- 169.09x
- Price / cash flow
- -76.65x
Enterprise value
- Enterprise value
- KRW 2.11T
- EV / sales
- 155.04x
- EV / EBITDA
- -53.90x
- EV / EBIT
- -50.88x
- Market cap
- KRW 2.31T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026